Jafron Biomedical Co.,Ltd. (SHE:300529)
26.69
+0.59 (2.26%)
Apr 1, 2025, 2:45 PM CST
Jafron Biomedical Revenue
Jafron Biomedical had revenue of 700.07M CNY in the quarter ending September 30, 2024, with 47.74% growth. This brings the company's revenue in the last twelve months to 2.63B, up 34.86% year-over-year. In the year 2023, Jafron Biomedical had annual revenue of 1.92B, down -22.84%.
Revenue (ttm)
2.63B
Revenue Growth
+34.86%
P/S Ratio
8.06
Revenue / Employee
1.09M
Employees
2,408
Market Cap
20.69B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.92B | -569.09M | -22.84% |
Jan 1, 2023 | 2.49B | -184.02M | -6.88% |
Jan 1, 2022 | 2.68B | 724.67M | 37.15% |
Dec 31, 2020 | 1.95B | 518.96M | 36.24% |
Dec 31, 2019 | 1.43B | 415.31M | 40.86% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 27.98B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Shanghai United Imaging Healthcare | 10.30B |
Sichuan Biokin Pharmaceutical | 5.82B |